A Review of
Molecular Mechanisms of the Anti-Leukemic Effects of Phenolic Compounds in
Honey
Int J Mol Sci, 2012 Nov 15
Hematologic
malignancies constitute about 9% of all new cases of cancers as reported via
the GLOBOCAN series by International Agency for Research on Cancer (IARC) in
2008. So far, the conventional therapeutic and surgical approaches to cancer
therapy have not been able to curtail the rising incidence of cancers,
including hematological malignancies, worldwide. The last decade has witnessed
great research interest in biological activities of phenolic compounds that
include anticancer, anti-oxidation and anti-inflammation, among other things.
A large
number of anticancer agents combat cancer through cell cycle arrest, induction
of apoptosis and differentiation, as well as through inhibition of cell growth
and proliferation, or a combination of two or more of these mechanisms. Various
phenolic compounds from different sources have been reported to be promising
anticancer agents by acting through one of these mechanisms.
Honey,
which has a long history of human consumption both for medicinal and
nutritional uses, contains a variety of phenolic compounds such as flavonoids,
phenolic acids, coumarins and tannins.
This paper
presents a review on the molecular mechanisms of the anti-leukemic activity of
various phenolic compounds on cell cycle, cell growth and proliferation and
apoptosis, and it advocates that more studies should be conducted to determine
the potential role of honey in both chemoprevention and chemotherapy in
leukemia.
No comments:
Post a Comment